Le Lézard
Classified in: Health, Business
Subject: CXP

Growing Global Demand for ESP Disc Replacements Leads to Formation of Independent Company -- Spine Innovations to Launch October 1


HEIMSBRUNN, France, Oct. 1, 2020 /PRNewswire/ -- The growing global demand for ESP disc replacements has led to the creation of an independent company called Spine Innovations, scheduled to launch on October 1, 2020. The new company will take over the entire spine business of its parent company FH Orthopedics, demonstrating its ongoing commitment to the worldwide spine device market. Spine Innovations, which will be based in Heimsbrunn, will maintain a strong focus on sales and marketing of ESP disc replacements while laying the groundwork for future technological advances.

Clinical evaluation of ESP disc replacements first started in 2004 and led to CE marks for the LP-ESP® prosthesis (lumbar disc replacement) in 2006 and the CP-ESP® prosthesis (cervical disc replacement) in 2012. A dedicated spine business unit was established in 2014 to push marketing of the devices. Now, just six years later, these products are available in more than 12 countries worldwide, and an ESP disc is implanted every 20 minutes in the world. Spine Innovations is positioned to become a leading actor in the total disc replacement market by building on that explosive market growth, and its status as an independent subsidiary will allow even greater focus and responsiveness to the needs of patients and surgeons.

Total disc replacements are used by surgeons to replace degenerated natural discs. The LP-ESP and CP-ESP prostheses offer an advanced solution by utilizing patented viscoelastic technology to mimic the characteristics of natural discs and provide similar motion behavior. This helps to restore normal function and protect adjacent levels. Clinical studies and follow-ups have confirmed that patients are often able to resume sports and work activities. Surgeons have also noted that many patients are relatively young, physically active, well informed about devices and surgical options, and willing to travel abroad specifically to receive ESP disc replacements when they are not available in the patient's home country.

At Spine Innovations, our team is dedicated to collaborating with expert surgeons to provide the most effective and innovative technologies for the health of their patients. Please visit www.spine-innovations.com to learn more about our company or www.esp-disc.com for more information on our ESP disc replacements.

For more information, contact:

Eric Hermann
Spine Innovations Sales and Marketing Director
[email protected]
+33 6 14 28 82 30

Sandrine Carle
CEO
[email protected]

Spine Innovations Logo

Photo - https://mma.prnewswire.com/media/1295105/Spine_Innovations_rachis.jpg

Logo - https://mma.prnewswire.com/media/1295104/Spine_Innovations_Logo.jpg


These press releases may also interest you

at 08:55
MAIA Biotechnology, Inc., ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of...

at 08:53
According to the Corporate Whistleblower Center, "We have by far the most robust initiative in the nation related to extremely short-staffed long-term care facilities billing Medicare-Medicaid as if they were fully staffed. In August of 2023 we...

at 08:52
Navamedic ASA (OSE: Nava) will be presenting its 1st quarter 2024 results on Tuesday, April 30, 2024. The presentation will be held at Haakon VIIs gate 2 in Oslo and the event will start at 08.30 CET. A link to the webcast and the presentation will...

at 08:50
Response Pharmaceuticals, Inc., a clinical stage company focused on weight management and metabolic health in high-risk populations, today announced positive topline results from its Phase 1b clinical trial evaluating the safety and efficacy of...

at 08:47
Dr. Mary C. McCluskey, psychotherapist, and author revitalizes Dr. Alfred Adler, the "Pioneer in the Prevention of Mental Health Disorders" and Dr. Pierre Janet "Father of Trauma Treatment Theory" using a time-traveling hot air balloon to create a...

at 08:45
The "Peptide Synthesis: Global Markets 2023-2028" report has been added to ResearchAndMarkets.com's offering. The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of...



News published on and distributed by: